886364-86-9

Usage

Uses

Used in Pharmaceutical Industry:
5-BROMO-4-METHYL-PYRIDINE-2-CARBONITRILE is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs and biologically active compounds, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical industry, 5-BROMO-4-METHYL-PYRIDINE-2-CARBONITRILE serves as a key intermediate in the synthesis of agrochemicals. Its properties make it suitable for the development of pesticides, herbicides, and other agricultural chemicals, enhancing crop protection and yield.
Used in Materials Science:
5-BROMO-4-METHYL-PYRIDINE-2-CARBONITRILE is utilized in materials science for the synthesis of various materials with specific properties. Its incorporation into the development of new materials can lead to advancements in areas such as polymers, coatings, and other specialized materials.
Used in Medicinal Chemistry Research:
5-BROMO-4-METHYL-PYRIDINE-2-CARBONITRILE is used as a research compound in medicinal chemistry. Its potential anti-inflammatory and antiviral properties make it an important compound for studying and developing new therapeutic agents to address various health conditions.

Upstream product

• 98198-48-2 2-amino-5-bromo-4-methylpyridine 

Downstream Products

• 1070973-08-8 5-[2-chloro-4-hydroxy-5-(2,3,4,5-tetrahydro-benzo[b]azepine-1-sulfonyl)-phenyl]-4-methyl-pyridine-2-carbonitrile 
• 1070889-90-5 4-chloro-3-(6-cyano-4-methyl-pyridin-3-yl)-N-(2-hydroxy-phenyl)-N-methyl-benzamide 
• 1070889-97-2 4-chloro-3-(6-cyano-4-methyl-pyridin-3-yl)-N-[2-(3-hydroxy-propoxy)-phenyl]-N-methyl-benzamide 
• 1070890-06-0 3-(2-{[4-chloro-3-(6-cyano-4-methyl-pyridin-3-yl)-benzoyl]-methyl-amino}-phenoxy)-propionic acid 
• 1256792-51-4 5-hydroxy-4-methylpyridine-2-carbonitrile 
• 1070973-10-2 3-[5-chloro-4-(6-cyano-4-methyl-pyridin-3-yl)-2-(2,3,4,5-tetrahydro-benzo[b]azepine-1-sulfonyl)-phenoxy]-propionic acid 
• 1070973-11-3 5-[2-chloro-4-(3-hydroxy-propoxy)-5-(2,3,4,5-tetrahydro-benzo[b]azepine-1-sulfonyl)-phenyl]-4-methyl-pyridine-2-carbonitrile 
• 1413285-70-7 2-[[6-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-4-methyl-3-pyridyl]sulfanyl]acetic acid 
• 1413285-69-4 ethyl 2-[[6-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-4-methyl-3-pyridyl]sulfanyl]acetate 
• 1309959-26-9 5-bromo-2-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-4-methyl-pyridine 
• 1413285-68-3 1-(5-bromo-4-methyl-2-pyridyl)ethanone 

Relevant academic research and scientific papers

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure, wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates, and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.